Sort
3,198 grants matching “mrna vaccine”
Advancement of poxvirus inhibitor
$590,147John H Connor · Boston University Medical Campus · R01 · FY2021 · AI
Vaccina Virus DNA Topoisomerase
$589,448Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2010 · GM
RAPs-mediated post-transcriptional control in Apicomplexan parasites
$588,320Karine Gaelle Le Roch · University Of California Riverside · R01 · FY2018 · AI
Immune cell control of ovarian cancer
$587,759Christina Annunziata · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
How Distinct Age-Associated B Cell Subsets Can Protect the Aged from Influenza
$586,250Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R01 · FY2024 · AI
Pneumococcal Biofilms in Otitis Media
$586,221Allegheny-Singer Research Institute · R01 · FY2003 · DC
How Distinct Age-Associated B Cell Subsets Can Protect the Aged from Influenza
$586,086Susan L Swain · Univ Of Massachusetts Med Sch Worcester · R01 · FY2025 · AI
Pathogenesis of Glaucomatous Optic Nerve Damage
$585,582Harry Alan Quigley · Johns Hopkins University · R01 · FY2009 · EY
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$584,740Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
$584,674Yogesh K Gupta · University Of Texas Hlth Science Center · R01 · FY2024 · AI
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
$584,674Yogesh K Gupta · University Of Texas Hlth Science Center · R01 · FY2025 · AI
Mechanism-based Targeting of the RNA Processing Machinery of SARS-CoV-2
$584,674Yogesh K Gupta · University Of Texas Hlth Science Center · R01 · FY2023 · AI
Evaluation of the ability of Mucosal Adjuvant Properties of an HIV mRNA vaccine to enhance protection provided by ADCC and Efferocytosis of Infected Cells
$584,220Maria Ferrari · Bioqual, Inc. · N01 · FY2022 · AI
Dengue virus mRNA lipid nanoparticle vaccine
$583,700Justin Richner · University Of Illinois At Chicago · R01 · FY2022 · AI
Biology and Therapy of Lymphopenia
$583,633Crystal Mackall · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Chemical Synthesis of Long Oligonucleotides
$583,025Shiyue Fang · Michigan Technological University · · FY2025 · MPS
Vaccina Virus DNA Topoisomerase
$582,718Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2011 · GM
RNA epigenetic modifications in SARS-CoV-2
$582,618Jianrong Li · Ohio State University · R01 · FY2025 · AI
Unraveling Human T Follicular Helper Cell Development
$581,189Philip A Mudd · Washington University · R01 · FY2023 · AI
Development of vaccines targeting a tick-borne phlebovirus
$581,039Paul F Bates · University Of Pennsylvania · R01 · FY2023 · AI
Modulation of internal ribosome entry by ribosomal protein RPS25
$580,275Peter Sarnow · Stanford University · R01 · FY2018 · AI
Novel vaccine antigens against N. gonorrhoeae
$580,195Paola Massari · Tufts University Boston · R01 · FY2022 · AI
Identification of human tumor-associated antigens
$579,726Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Vaccina Virus DNA Topoisomerase
$578,913Stewart H Shuman · Sloan-Kettering Inst Can Research · R37 · FY2009 · GM
Modulation of internal ribosome entry by ribosomal protein RPS25
$578,724Peter Sarnow · Stanford University · R01 · FY2017 · AI